BeOne Medicines
ONC
#636
Rank
ยฃ28.56 B
Marketcap
ยฃ258.18
Share price
-1.23%
Change (1 day)
56.89%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: ยฃ28.56 Billion

As of January 2026 BeOne Medicines has a market cap of ยฃ28.56 Billion. This makes BeOne Medicines the world's 636th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ28.56 B11.3%
2025ยฃ25.66 B57.28%
2024ยฃ16.32 B5.47%
2023ยฃ15.47 B-26.4%
2022ยฃ21.02 B2.11%
2021ยฃ20.58 B18.57%
2020ยฃ17.36 B122.85%
2019ยฃ7.79 B18.35%
2018ยฃ6.58 B99.94%
2017ยฃ3.29 B237.3%
2016ยฃ0.97 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of BeOne Medicines was reported to be:

ยฃ28.56 Billion
by Nasdaq info icon info icon
ยฃ28.56 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
ยฃ15.56 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.76 B-97.31%๐Ÿ‡บ๐Ÿ‡ธ USA